Organometallics
Article
736 s, 690 s, 659 w, 632 w, 532 w, 505 w cm−1. Anal. Calcd for
C26H20N2: C, 86.64; H, 5.59; N, 7.77. Found: 86.42; H, 5.70; N, 7.70.
Reaction of 10 with 6d. General procedure B was followed with
4,5-dihydro-4,4-dimethyl-2-phenyloxazole (10; 175.2 mg, 1.0 mmol)
and styryl acetate (6d; 486.6 mg, 3 mmol), except that 2 mmol of 2,6-
lutidine (214.3 mg) was used as an additive. Column chromatography
(10/1 hexane/EtOAc) afforded 11 (299.8 mg, 0.79 mmol) as a pale
yellow powder in 79% yield: 1H NMR (CDCl3, 399.7 MHz) δ 1.54 (s,
6H, CH3), 4.20 (s, 2H, CH2), 7.10 (d, J = 16.6 Hz, 2H, ArH), 7.29 (t, J
= 7.3 Hz, 2H, ArH), 7.35 (d, J = 16.6 Hz, 2H, ArH), 7.38 (t, J = 7.3
Hz, 4H, ArH), 7.43 (t, J = 7.8 Hz, 1H, ArH), 7.50 (d, J = 7.3 Hz, 4H,
ArH), 7.64 (d, J = 7.8 Hz, 2H, ArH); 13C NMR (CDCl3, 100.4 MHz)
δ 28.7, 68.4, 79.2, 124.3, 125.7, 126.5, 127.0, 127.7, 128.6, 129.7, 131.0,
137.0, 137.2, 161.1; IR (KBr) 2966 w, 1666 s, 1598 w, 1495 m, 1453
m, 1437 w, 1364 w, 1346 w, 1289 s, 1250 w, 1210 m, 1096 m, 1075 w,
1029 s, 977 m, 961 s, 918 w, 873 w, 791 m, 738 s, 726 m, 693 s, 617 w,
526 m, 506 m cm−1; HRMS (ESI) calcd for [M + H]+ (C27H26NO)
m/z 380.2014, found 380.2003.
Reaction of 16 with 6d. General procedure B was followed with
2-methyl-4-phenylthiazole (16; 175.3 mg, 1 mmol) and styryl acetate
(6d; 486.6 mg, 3 mmol). Column chromatography (10/1/0.1 hexane/
EtOAc/Et3N), followed by gel permeation chromatography (GPC)
and bulb-to-bulb distillation, afforded 17a (61.0 mg, 0.22 mmol) as a
white solid in 22% yield: 1H NMR (CDCl3, 270.1 MHz) δ 2.81 (s, 3H,
CH3), 7.04 (d, J = 16.2 Hz, 1H, ArCHCHAr), 7.11 (s, 1H, ArH),
7.22−7.47 (m, 8H, ArH and ArCHCHAr), 7.70 (t, J = 7.0 Hz, 2H,
ArH); 13C NMR (CDCl3, 67.8 MHz) δ 19.3, 116.9, 126.5, 126.6,
127.5, 127.6, 128.1, 128.2, 128.6, 129.9, 130.0, 133.8, 136.0, 137.6,
154.0, 165.2.; LRMS (EI) m/z (% relative intensity) 277 (M+, 27), 236
(13), 235 (11), 203 (10), 202 (24), 201 (17), 200 (100), 186 (48),
115 (14), 101 (11), 59 (11), 51 (10); IR (neat) 3052 s, 3023 s, 2919
m, 1598 m, 1494 s, 1448 s, 1434 s, 1307 m, 1214 w, 1170 s, 1101 w,
1027 s, 962 s, 856 w, 790 w, 759 s, 728 m, 692 s, 647 w, 547 m, 512 m
cm−1. Anal. Calcd for C18H15NS: C, 77.94; H, 5.45; N, 5.05. Found:
77.87; H, 5.42; N, 4.99. Distyrylation product 17b (227.7 mg, 0.6
mmol) was also isolated in 60% yield from the crude material, as
described previously.35
Reaction of 30 with 6d. General procedure B was followed with
2-(3-thienyl)pyridine (30; 161.22 mg, 1 mmol) and styryl acetate (6d;
486.6 mg, 3 mmol). Column chromatography (9/1/0.1 hexane/
EtOAc/Et3N), followed by gel permeation chromatography (GPC)
and bulb-to-bulb distillation, afforded a mixture of 31 (259.5 mg) and
α,β-dialkenylated compound as a colorless oil in 89% yield of 31,
which was determined on the basis of H NMR spectra: H NMR
(CDCl3, 270.1 MHz) δ 7.07 (d, J = 16.5 Hz, 1H, ArCHCHAr),
7.19−7.60 (m, 10H, ArH and ArCHCHAr), 7.74 (td, J = 7.6 Hz, 1.9
Hz, 1H, ArH), 8.69 (d, J = 4.9 Hz, 1H, ArH); 13C NMR (CDCl3, 67.8
MHz) δ 121.6, 122.4, 122.9, 126.1, 126.3, 126.7, 127.4, 128.5, 130.6,
136.3, 136.7, 137.2, 139.2, 149.6, 152.8; LRMS (EI) m/z (% relative
intensity) 263 (M+, 8), 187 (12), 186 (100), 51 (13); IR (neat) 3077
s, 3054 s, 3025 s, 1596 s, 1581 s, 1563 s, 1523 s, 1492 s, 1467 s, 1438 s,
1423 s, 1288 m, 1247 m, 1220 m, 1153 s, 997 m, 960 s, 836 s, 782 s,
754 s, 692 s, 646 s, 619 m, 551 s, 503 m cm−1. Anal. Calcd for
C17H13NS: C, 77.53; H, 4.98; N, 5.32. Found: C, 77.26; H, 4.92; N,
5.21.
1
1
Reaction of 32 with 6i. General procedure B was followed with 2-
(1H-pyrrol-1-yl)pyridine (32; 72.1 mg, 0.5 mmol) and 2-(1,3-
dimethyl-1H-indol-2-yl)ethenyl acetate (6i; 573.2 mg, 2.5 mmol),
except that the reaction was performed on a half scale (4, 7.9 mg,
0.025 mmol; toluene, 0.75 mL), 2.5 mmol, not 1.5 mmol, of the
alkenyl acetate was used, and 1 mmol of 2,6-lutidine (107.15 mg) was
also employed as an additive. Column chromatography (gradient
elution, 10/1−6/1 hexane/EtOAc) afforded 33b (193.0 mg, 0.4
mmol) as an orange solid in 80% yield: 1H NMR (CDCl3, 400.1
MHz) δ 2.27 (s, 6H, CCH3), 3.67 (s, 6H, NCH3), 6.58 (d, J = 16.3 Hz,
2H, ArCHCHAr), 6.78 (s, 2H, ArH), 6.90 (d, J = 16.3 Hz, 2H,
ArCHCHAr), 7.06 (ddd, J = 7.9, 6.8, 1.3 Hz, 2H, ArH), 7.14−7.22
(m, 4H, ArH), 7.38−7.43 (m, 2H, ArH), 7.48 (apparent br d, J = 7.8
Hz, 2H, ArH), 7.89 (ddd, J = 7.8, 7.6, 1.9 Hz, 1H, ArH), 8.72 (ddd, J =
4.8, 1.9, 0.7 Hz, 1H, ArH); 13C NMR (CDCl3, 100.5 MHz) δ 10.2,
30.4, 108.5, 108.7, 109.2, 115.2, 118.4, 119.0, 121.0, 121.9, 123.3,
123.5, 128.6, 134.6, 134.6, 137.3, 138.3, 149.7, 151.1; IR (KBr) 2927
w, 1585 w, 1469 s, 1438 m, 1356 m, 945 w, 735 s cm−1; HRMS (ESI)
calcd for [M + Na]+ (C33H30N4Na1) m/z 505.2368, found 505.2374.
Reaction of 34 with 6d. General procedure B was followed with
4,5-dihydro-4,4-dimethyl-2-(1H-pyrrol-1-yl)oxazole (34; 98.1 mg, 0.5
mmol) and styryl acetate (6d; 405.5 mg, 2.5 mmol), except that the
reaction was performed on a half scale (4, 7.9 mg, 0.025 mmol;
toluene, 0.75 mL), 2.5 mmol, not 1.5 mmol, of styryl acetate was used,
and 1 mmol of 2,6-lutidine (107.15 mg) was also employed as an
additive. Column chromatography (10/1 hexane/EtOAc) afforded 35
Reaction of 18 with 6d. General procedure B was followed with
1-phenyl-1H-pyrazole (18; 144.2 mg, 1 mmol) and styryl acetate (6d;
486.6 mg, 3 mmol). Column chromatography (9/1/0.1 hexane/
EtOAc/Et3N), followed by gel permeation chromatography (GPC)
and bulb-to-bulb distillation, afforded 19a (137.9 mg, 0.56 mmol) as a
1
colorless oil in 56% yield: H NMR (CDCl3, 270.1 MHz) δ 6.47 (s,
1H, ArH), 6.94 (d, J = 16.5 Hz, 1H, ArCHCHAr), 7.06 (d, J = 16.5
Hz, 1H, ArCHCHAr), 7.26−7.46 (m, 8H, ArH), 7.66 (d, J = 2.2 Hz,
1H, ArH), 7.75−7.78 (m, 2H, ArH); 13C NMR (CDCl3, 67.8 MHz) δ
106.5, 123.8, 126.2, 126.4, 126.6, 127.8, 128.0, 128.3, 128.5, 131.1,
131.4, 132.8, 136.8, 138.6, 140.6; LRMS (EI) m/z (% relative
intensity) 246 (M+, 35), 245 (41), 218 (12), 217 (14), 170 (11), 169
(100), 168 (13), 89 (11), 77 (10), 76 (13), 51 (14); IR (neat) 3027 m,
1598 w, 1573 w, 1515 s, 1496 s, 1461 s, 1415 w, 1394 s, 1328 m, 1191
w, 1095 w, 1045 m, 1020 w, 964 m, 937 m, 755 s, 728 m, 692 s, 622 w,
551 w, 522 m cm−1. Anal. Calcd for C17H14N2: C, 82.90; H, 5.73; N,
11.37. Found: C, 82.70; H, 5.67; N, 11.27. The synthetic procedure
also provided distyrylation product 19b (52.3 mg, 0.15 mmol), which
was similarly isolated as a white solid in 15% yield: 1H NMR (CDCl3,
270.1 MHz) δ 6.49 (d, J = 16.4 Hz, 2H, ArCHCHAr), 6.54 (d, J =
2.2 Hz, 1H, ArH), 7.02 (d, J = 15.9 Hz, 2H, ArCHCHAr), 7.21−
7.31 (m, 10H, ArH), 7.48 (t, J = 7.6 Hz, 1H, ArH), 7.55 (d, J = 1.9 Hz,
1H, ArH), 7.71 (d, J = 7.8 Hz, 2H, ArH), 7.87 (d, J = 1.6 Hz, 1H,
ArH); 13C NMR (CDCl3, 67.8 MHz) δ 106.5, 123.1, 124.7, 126.7,
128.0, 128.6, 129.4, 131.5, 132.9, 136.2, 136.6, 136.9, 140.7; LRMS
(EI) m/z (% relative intensity) 349 (22), 348 (M+, 98), 347 (100),
272 (19), 271 (84), 268 (10), 254 (12), 241 (13), 193 (13), 165 (10),
152 (11), 135 (24), 134 (10), 115 (10), 77 (17), 51 (15); IR (KBr)
3133 m, 3079 w, 3043 m, 1625 m, 1581 m, 1511 m, 1492 m, 1461 s,
1415 m, 1390 m, 1328 m, 1213 m, 1072 m, 1054 m, 1022 m, 962 s,
941 m, 854 w, 796 s, 775 s, 736 s, 690 s, 624 w, 553 w, 526 m, 505 m
cm−1. Anal. Calcd for C25H20N2: C, 86.17; H, 5.79; N, 8.04. Found: C,
85.93; H, 5.72; N, 8.03.
1
(172.2 mg, 0.43 mmol) as a pale yellow powder in 85% yield: H
NMR (CDCl3, 270.1 MHz) δ 1.51 (s, 6H, CH3), 4.27 (s, 2H, CH2),
6.62 (s, 2H, ArH), 6.91 (d, J = 16.2 Hz, 2H, ArCHCHAr), 7.21 (t, J
= 7.3 Hz, 2H, ArH), 7.30 (d, J = 16.2 Hz, 2H, ArCHCHAr), 7.33
(dd, J = 7.8, 7.3 Hz, 4H, ArH), 7.44 (d, J = 7.8 Hz, 4H, ArH); 13C
NMR (CDCl3, 100.5 MHz) δ 28.2, 66.8, 79.4, 109.9, 117.8, 126.1,
127.2, 127.3, 128.6, 134.6, 137.6, 152.8; IR (KBr) 3056 w, 3030 w,
2974 m, 2964 m, 2927 w, 1726 w, 1663 s, 1622 m, 1596 m, 1573 w,
1547 w, 1495 m, 1463 m, 1447 m, 1415 s, 1367 s, 1333 m, 1285 w,
1259 m, 1231 m, 1201 m, 1180 m, 1076 s, 1031 m, 1011 w, 949 s, 839
w, 817 w, 774 s, 747 s, 723 w, 693 s, 647 w, 619 w, 549 w, 507 w cm−1;
HRMS (ESI) calcd for [M + Na]+ (C25H24N2NaO) m/z 391.1786,
found 391.1769.
Preparation of 6i. The literature procedure59 was followed with
2.03 g of 2-(1,3-dimethyl-1H-indol-2-yl)acetaldehyde (10.8 mmol),
and the reaction was carried out for 16.5 h. Column chromatography
(15/1 hexane/EtOAc) afforded 6i (1.77 g, 7.7 mmol) as an orange
1
solid in 71% yield (E:Z = 66:34): H NMR (CDCl3, 270.1 MHz) δ
2.16 (s, 3H, CH3 (Z isomer)), 2.23 (s, 3H, CH3 (E isomer)), 2.26 (s,
3H, CH3 (Z isomer)), 2.38 (s, 3H, CH3 (E isomer)), 3.65 (s, 3H,
NCH3 (Z isomer)), 3.70 (s, 3H, NCH3 (E isomer)), 5.85 (d, J = 7.2
Hz, 1H, OCHCHAr (Z isomer)), 6.47 (d, J = 12.8 Hz, 1H, OCH
CHAr (E isomer)), 7.06−7.14 (m, 1H, ArH), 7.16−7.29 (m, 2H,
ArH), 7.43 (d, J = 7.2 Hz, 1H, OCHCHAr (Z isomer)), 7.52−7.58
(m, 1H, ArH), 7.65 (d, J = 12.8 Hz, 1H, OCHCHAr (E isomer));
13C NMR (E isomer, CDCl3, 100.5 MHz) δ 9.90, 20.6, 30.2, 104.8,
N
dx.doi.org/10.1021/om401204h | Organometallics XXXX, XXX, XXX−XXX